The identification of C. difficile carriers who have the potential to produce toxin can take up to four days, delaying patient isolation and increasing the chance of nosocomial spread of infection. Here, Laura Nottle considers the performance and benefits of a tcdB gene detection assay.
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic...
Learn more »
The Holiday Inn - Kensington Forum, 97 Cromwell Road, London SW7 4DN
21 January 2019
Royal College of Paediatrics and Child Health, 5-11 Theobalds Road, London WC1X 8SH
14 February 2019
The Royal College of Pathologists
28 February 2019
1-3 April 2019
1-3 May 2019
Molecular diagnostics and LAMP technology
Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.
Don't miss out on the latest news affecting UK Pathology Services, Biomedical Scientists and Medical Laboratory Professionals. Register FREE for your regular copy of Pathology In Practice now, and enjoy FREE access to feature article content and to the digital version of Pathology In Practice along with regular news delivered to your inbox.